Table 2 Baseline characteristics of the included studies
Reference | Study design | Number of patients | Male/ female ratio | Age (year) | Follow-up time (month) |
|---|---|---|---|---|---|
Abulaiti et al | RC | 53 | 39/14 | 38.8(19–65) | nr |
Catagni et al | RC | 86 | 77/9 | BFT, 43 (23 to 54) | 45.6(26.4–108) |
TFT, 42 (33 to 51.5) | |||||
Li et al | RC | 26 | 20/6 | 40.4(22–56) | 28.5(13–38) |
Liu et al | R | 282 | 243/39 | 40 (18–65) | ≥ 24 |
Yushan et al | RC | 37 | 28/9 | 40.1(18–57) | 29.4(24–38) |